InvestSMART

Clarity Pharmaceuticals Ltd (ASX: CU6) - Announcements

Current share price for CU6 : $1.753 0.073 (3.97%)+

ASX company news and announcements for Clarity Pharmaceuticals Ltd (CU6) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Clarity Pharmaceuticals Ltd (CU6) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Clarity Pharmaceuticals Ltd (CU6), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Clarity Pharmaceuticals Ltd (CU6)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$654 Chairperson Address AGM 25 Nov 2025 9:50AM $3.640 $1.753 fallen by 51.85%
$654 AGM MD Presentation 25 Nov 2025 9:29AM $3.640 $1.753 fallen by 51.85%
$654 Ceasing to be a substantial holder 24 Nov 2025 8:16AM $3.580 $1.753 fallen by 51.05%
$654 Becoming a substantial holder 14 Nov 2025 8:21AM $4.060 $1.753 fallen by 56.83%
$654 Cleansing Notice 11 Nov 2025 10:01AM $4.630 $1.753 fallen by 62.15%
$654 Application for quotation of securities - CU6 11 Nov 2025 9:58AM $4.620 $1.753 fallen by 62.07%
$654 Ceasing to be a substantial holder 7 Nov 2025 8:23AM $4.480 $1.753 fallen by 60.88%
$654 Change in substantial holding 5 Nov 2025 8:24AM $4.840 $1.753 fallen by 63.79%
$654 Change in substantial holding 4 Nov 2025 5:06PM $4.840 $1.753 fallen by 63.79%
$654 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2025 10:09AM $4.890 $1.753 fallen by 64.16%
$654 Response to ASX Aware Letter 27 Oct 2025 6:34PM $4.520 $1.753 fallen by 61.23%
$654 Ceasing to be a substantial holder 24 Oct 2025 4:24PM $4.510 $1.753 fallen by 61.14%
$654 Becoming a substantial holder 23 Oct 2025 6:19PM $4.590 $1.753 fallen by 61.82%
$654 Canaccord Drug and Device Conference presentation 21 Oct 2025 2:29PM $4.800 $1.753 fallen by 63.49%
$654 Notice of Annual General Meeting/Proxy Form 21 Oct 2025 11:29AM $5.170 $1.753 fallen by 66.10%
$654 Clarity signs copper-67 Supply Agreement with Nusano 16 Oct 2025 9:27AM $4.570 $1.753 fallen by 61.65%
$654 Co-PSMA trial achieves primary endpoint 14 Oct 2025 9:26AM $5.380 $1.753 fallen by 67.43%
$654 Becoming a substantial holder 9 Oct 2025 4:59PM $5.610 $1.753 fallen by 68.76%
$654 Change in substantial holding 8 Oct 2025 8:23AM $5.150 $1.753 fallen by 65.97%
$654 Data on SAR-bisFAP to be presented at WMIC 2025 2 Oct 2025 9:38AM $3.750 $1.753 fallen by 53.27%
$654 Clarity response to US tariff announcement 26 Sep 2025 1:09PM $3.740 $1.753 fallen by 53.14%
$654 Ceasing to be a substantial holder 23 Sep 2025 5:38PM $3.590 $1.753 fallen by 51.18%
$654 Date of AGM 23 Sep 2025 4:51PM $3.590 $1.753 fallen by 51.18%
$654 Ceasing to be a substantial holder 23 Sep 2025 3:35PM $3.550 $1.753 fallen by 50.63%
$654 Becoming a substantial holder 18 Sep 2025 4:37PM $3.530 $1.753 fallen by 50.35%

76 - 100 of 520 results

Page 4 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.